MedPath

Treatment in Occupational Therapy With Significant Activities to Improve Quality of Life

Not Applicable
Completed
Conditions
Dementia
Interventions
Behavioral: To with significance activities
Registration Number
NCT05359978
Lead Sponsor
Universidad de Burgos
Brief Summary

We followed a pretest-posttest non-equivalent control group experimental design study comparing two cohorts of patient with different types of dementia.

Approximately 250 patients will be screened to achieve 240 participants, divided in two cohorts (120 each), furthermore each cohorts was divided in other two groups (experimental group (60 each) and control group (60 each) the first one followed up by private centres in Spain endowed with Occupational Therapy and the second by public centres in the region of Modena.

Detailed Description

The course of dementia goes through different stages and during the moderate and advanced stages cognitive decline and functional deterioration are frequently accompanied by the so-called behavioural and psychological symptoms of dementia (BPSD), that put severe stress on the persons with dementia (PwD), on their families and on the health system. Worldwide consensus guidelines recommend non-pharmacological approaches to be first line.

The occupational therapist studies human activity as a therapeutic resource to prevent and treat physical and/or psychosocial difficulties, in order to improve the person's quality of life.

Subjects were not randomly assigned to different treatment groups (control group and experimental group); instead, consecutive sampling was chosen by assigning subjects based on an odd-and-even-numbered technique (odd subjects were assigned to the control group and even subjects to the experimental group). Both groups presented the same pathological, cultural, and sexual characteristics, and belonged to the same age group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
240
Inclusion Criteria
  • a diagnosis of primary dementia (DSM V)
  • a MMSE score ≤ 24
  • a NPI global score ≥ 32/144
  • a treatment with significance activities in Occupational Therapy
  • live in a nursing home
Exclusion Criteria
  • presence of uncontrolled medical disease potentially contributing to the cognitive decline and BPSD

    • concomitant psychiatric disorders or chronic alcoholism
    • concomitant diseases severe enough to reduce life expectancy < 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
cardsTo with significance activitiesparticipants received 2 days at week during 30 minutes
significance activitiesTo with significance activitiesparticipants received 2 days a week during 30 minutes
Primary Outcome Measures
NameTimeMethod
NPI2 days

- The NPI-Q Spanish version offers the possibility to use a reliable and brief instrument that can be used as a screening in the evaluation of neuropsychiatric symptoms in dementia and associated caregiver distress

Barthel2 days

- Evidence suggests that (Barthel Index) BI is a valid measure of activities of daily living; sensitivity to change is limited at extremes of disability (floor and ceiling effects), and reliability of standard BI assessment is acceptable

Tinetti2 days

- The Tinetti test has been recommended and widely used in the elderly to assess mobility, balance and gait, and predict falls. Different versions can be found. A systematic literature search identified 37 publications on the Tinetti test and falls.

MMSE2 days

- The MMSE fulfilled its original goal of providing a brief screening test that quantitatively assesses the severity of cognitive impairment and documents cognitive changes occurring over time

CDR2 days

- The Clinical Dementia Rating (CDR) has demonstrated high validity and reliability for this purpose, but it requires a considerable amount of data to be collected both from the patient and from an informant.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Olalla Saiz Vazquez

🇪🇸

Burgos, Spain

© Copyright 2025. All Rights Reserved by MedPath